Le Lézard
Classified in: Health, Sports and recreation
Subject: NPT

Yankees Pitcher David Robertson Aims to Strike Out Pancreatic Cancer



MANHATTAN BEACH, Calif., Oct. 3, 2017 /PRNewswire-USNewswire/ -- As the Major League Baseball (MLB) playoffs begin today, New York Yankees relief pitcher David Robertson will be aiming to strike out more than just batters. With a new PSA supporting the Pancreatic Cancer Action Network (PanCAN), Robertson hopes to help end pancreatic cancer. Robertson's passion is driven by the memory of his father-in-law, Rick Cronin, who died from the disease in 2016.

"Rick and I were like best friends," said Robertson, a 2017 Marvin Miller Man of the Year nominee. "We fished together, bought a boat together, we had a lot of good times. His loss really hit home for me. We must do more for patients and their loved ones across the nation."

In the video, Robertson urges friends and fans to get involved with PanCAN to provide hope and improve outcomes for all pancreatic cancer patients.

Pancreatic cancer is the world's toughest cancer with a five-year survival rate of just 9 percent. The disease kills more people than breast cancer in the United States, and more than 53,000 Americans will be diagnosed with the disease this year. That's more than 145 mothers, daughters, fathers, sons, sisters, brothers, colleagues or friends who hear the dreaded news every single day.

Robertson and wife Erin first became involved with PanCAN as volunteers in 2009, neither having a connection to the disease. But six years later, Cronin was diagnosed and the Robertsons felt the effects of pancreatic cancer firsthand. Together the couple worked with increased determination to support patients fighting the disease and have continued to advocate for more awareness.   

"More time and research will give us a chance to detect the disease earlier and save lives," said Robertson. "Our hope is that no one else will have to go through the ending that our family had to experience. But we need more people to raise their voice, take action and donate to see the results."

Join the Robertsons and support the Pancreatic Cancer Action Network's urgent goal to double survival by 2020.  Follow updates from PanCAN on Twitter, Instagram and Facebook.  

About the Pancreatic Cancer Action Network

The Pancreatic Cancer Action Network (PanCAN) is dedicated to fighting the world's toughest cancer. In our urgent mission to save lives, we attack pancreatic cancer on all fronts: research, clinical initiatives, patient services and advocacy. Our effort is amplified by a nationwide network of grassroots support. We are determined to improve patient outcomes today and to double survival by 2020.

Media Contact:
Michael Rosen
Chief Communications Officer
Pancreatic Cancer Action Network
Direct: 646-844-1227; E-mail: mrosen@pancan.org

The Pancreatic Cancer Action Network (PanCAN) is dedicated to fighting the world's toughest cancer. In our urgent mission to save lives, we attack pancreatic cancer on all fronts: research, clinical initiatives, patient services and advocacy. Our effort is amplified by a nationwide network of grassroots support. We are determined to improve outcomes today and to double survival by 2020.

SOURCE Pancreatic Cancer Action Network


These press releases may also interest you

at 07:30
PUNE, India, October 23, 2017 /PRNewswire/ -- According to a new market research report "Surgical Drains/Wound Drainage Market by Product (Accessories, System (Open, Closed)), Type (Active, Passive), Application (Orthopedic, CVD, Thoracic,...

at 07:27
NUREMBERG, Germany, October 23, 2017 /PRNewswire/ -- Ziehm Vision FD has been recognized with the Silver Stevie Award as "Best new product of the year" in the "Health & Pharmaceuticals" category at the 2017 Stevie Awards ceremony on October 21 in...

at 07:10
SALT LAKE CITY, Oct. 23, 2017 /PRNewswire/ -- Incorporate Massage announces the first recipient for its Winning Woman Scholarship. The scholarship was available to women across the country currently enrolled in an...

at 07:05
SAN DIEGO, Oct. 23, 2017 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced positive...

at 07:04
/NOT FOR DISSEMINATION IN THE U.S. OR THROUGH U.S. NEWSWIRES/ TORONTO, Oct. 23, 2017 /CNW/ - Liberty Health Sciences Inc. (CSE:LHS) (OTCBB:LHSIF)  ("Liberty" or the "Company") announced that on October 20, 2017 the Board of Directors of the...

at 07:03
Rapid Micro Biosystems Awarded a Contract by Biomedical Advanced Research and Development Authority (BARDA) for the Implementation of a Rapid Sterility Test for Vaccines LOWELL, Mass., Oct. 23, 2017 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, a...




News published on 3 october 2017 at 08:00 and distributed by: